ArticleTherapeutic advances in gastroenterology2012
A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease.
Matthew S Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it